A study posted to the bioRxiv* preprint server tested the hypothesis that the angiotensin-converting enzyme 2 (ACE-2) receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not ...
A new study takes a closer look at one of the lesser known, but potential most serious side-effects of ACE inhibitor use -- facial, tongue and airway swelling -- and identifies a successful and less ...
The new data, published this week in JAMA Network Open, show that after adjusting for multiple variables, COVID-19 patients treated with ACE inhibitors and ARBs had a significantly lower risk of death ...
April 26 (UPI) --Taking a specific type of blood pressure medication increases levels of a protein that helps COVID-19 spread through the body, a study presented Monday during the American Society for ...
July 28 (UPI) --Some drugs prescribed to people with high blood pressure and congestive heart failure weaken the immune system's ability to fight off bacterial infections, a study published Wednesday ...
In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...
Suppression of the renin–angiotensin system (RAS) with angiotensin-converting enzyme (ACE) inhibitors has been generally accepted as a valuable therapeutic approach in hypertension. In addition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback